CONFIRMATIONS, LEGITIMATE QUESTIONS AND NEBULOUS ENTANGLEMENTS GERMANE TO AN INSTANT EPIDEMIC CENTERED ON A VIRUS WITH A QUESTIONABLE GENESIS

(Third article in a series of six)

The ultimate question in all of this is a simple one but it can also serve as a vector through which many perplexing questions can begin to be answered – Cui bono? Or, in conventional terms, who benefits?

Initially, in THIS article, we established that there was more to the mysterious coronavirus outbreak than we were being told. In the article, I outlined the lineage from the apparent first successful treatment in a Washington state medical clinic whereby the treatment – a prescription anti-viral medication called Remdesivir – can be traced back to a financially struggling Gilead Sciences looking for a financial booster shot, a George Soros funded entity called Unitaid and the effort to establish patent-sharing operations in China as predicated on royalties…